Catyalyst Pharmaceutical Partners (CPRX) Posts Q2 Loss of 6c/Share

August 15, 2013 8:14 AM

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

"We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found